Australian scientists behind the only locally-developed COVID-19 vaccine candidate concede they trail their rivals but say their product will be a more robust, better long-term option.
Experts from biotechnology giant CSL and the University of Queensland said continued investment in the development of their vaccine as well as emerging therapies was critical to prepare for future pandemics, even as Pfizer’s mRNA-based COVID-19 vaccine began to be rolled out internationally.
Loading...
Yolanda Redrup is the editor of the AFR Rich List. She previously reported on technology, healthcare and Street Talk. Connect with Yolanda on Twitter. Email Yolanda at yolanda.redrup@afr.com
